Dales Report Tests the Legal Case Against Broader Rescheduling

The Dales Report examined a legal argument that broader Schedule III treatment could fail over adult-use scope and treaty obligations, then contrasted it with DEA’s completed hearing record and final brief supporting movement from Schedule I. Oklahoma operators should treat the outcome as unresolved and plan separately for the existing medical framework and the still-contested broader rule.